CD4 and Bloom syndrome: The spleens of TLR9-KO mice treated with BLM showed a significantly higher proportion of TNFα + CD4 + Th1 cells compared to PBS-treated WT mice, BLM-treated WT mice, and BLM-treated TLR7-KO mice.